EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 183 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $443 | -38.0% | 65 | -69.0% | 0.00% | – |
Q3 2023 | $714 | -90.0% | 210 | -78.4% | 0.00% | -100.0% |
Q2 2023 | $7,144 | +556.6% | 972 | +825.7% | 0.00% | – |
Q1 2023 | $1,088 | -87.3% | 105 | -85.5% | 0.00% | -100.0% |
Q4 2022 | $8,562 | +756.2% | 725 | +1511.1% | 0.00% | – |
Q2 2022 | $1,000 | – | 45 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |